Meropenem and Rabeprazole sodium drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 156 people who take Meropenem and Rabeprazole sodium. Common interactions include drug eruption among females, and pyrexia among males.
The phase IV clinical study analyzes what interactions people who take Meropenem and Rabeprazole sodium have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
156 people who take Meropenem and Rabeprazole sodium together, and have interactions are studied.
What is Meropenem?
Meropenem has active ingredients of meropenem. Currently, eHealthMe is studying from 30,415 Meropenem users.
What is Rabeprazole sodium?
Rabeprazole sodium has active ingredients of rabeprazole sodium. It is used in gastroesophageal reflux disease. Currently, eHealthMe is studying from 14,654 Rabeprazole sodium users.
Number of Meropenem and Rabeprazole sodium reports submitted per year:
Meropenem and Rabeprazole sodium drug interactions by gender *:
Meropenem and Rabeprazole sodium drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Meropenem and Rabeprazole sodium?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
Related studies
Drug side effects by duration, gender and age:
- Meropenem side effects (30,415 reports)
- Rabeprazole sodium side effects (14,654 reports)
Common Meropenem drug interactions:
- Meropenem and Linezolid: 3,622 reports
- Meropenem and Fluconazole: 3,512 reports
- Meropenem and Furosemide: 3,387 reports
- Meropenem and Vancomycin: 2,702 reports
- Meropenem and Metronidazole: 2,674 reports
- Meropenem and Omeprazole: 2,352 reports
- Meropenem and Prednisolone: 2,318 reports
- Meropenem and Ceftriaxone: 2,248 reports
- Meropenem and Voriconazole: 2,224 reports
- Meropenem and Pantoprazole: 2,185 reports
Browse interactions between Meropenem and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Rabeprazole sodium drug interactions:
- Rabeprazole sodium and Aspirin: 1,821 reports
- Rabeprazole sodium and Methotrexate: 1,554 reports
- Rabeprazole sodium and Prednisone: 1,488 reports
- Rabeprazole sodium and Prednisolone: 1,401 reports
- Rabeprazole sodium and Humira: 1,398 reports
- Rabeprazole sodium and Furosemide: 1,315 reports
- Rabeprazole sodium and Amlodipine: 1,089 reports
- Rabeprazole sodium and Acetaminophen: 998 reports
- Rabeprazole sodium and Lasix: 879 reports
- Rabeprazole sodium and Allopurinol: 866 reports
Browse interactions between Rabeprazole sodium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on meropenem and rabeprazole sodium (the active ingredients of Meropenem and Rabeprazole sodium, respectively), and Meropenem and Rabeprazole sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Meropenem and Rabeprazole sodium.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Euthyrox and Drug Intolerance - 3 seconds ago
- Acetylsalicylic Acid and Lidocaine And Prilocaine drug interaction - 4 seconds ago
- Gentak and Clobex drug interaction - 4 seconds ago
- Arzerra and Methotrexate drug interaction - 5 seconds ago
- Septra and Ards (Acute Respiratory Distress Syndrome) - 21 seconds ago
- Macrodantin and Pruritus Generalised - 23 seconds ago
- Cosentyx and Glossitis - 23 seconds ago
- Trulicity and Omacor drug interaction - 25 seconds ago
- Nimodipine and Digoxin drug interaction - 28 seconds ago
- Losartan and Panniculitis - 29 seconds ago